Biogen to Present Positive Phase 2 Systemic Lupus Erythematosus Data at American College of Rheumatology 2020 MeetingGlobeNewsWire • 11/03/20
Why 2 of Warren Buffett's 3 Worst-Performing Stocks in October Are Great Picks to Buy Right NowThe Motley Fool • 11/03/20
European Medicines Agency Accepts Biogen's Aducanumab Marketing Authorization Application for Alzheimer's DiseaseGlobeNewsWire • 10/30/20
Biogen Inc. (BIIB) CEO Michel Vounatsos on Q3 2020 Results - Earnings Call TranscriptSeeking Alpha • 10/21/20
Abarca Details First Value-Based Agreement For Medicaid Members Prescribed Biogen ProductsPRNewsWire • 10/20/20
Biogen Alzheimer's Drug Headed For Unfavorable Vote, Says An Analyst's Mock PanelInvestors Business Daily • 10/19/20
Can Either of These Little-Known Biotechs Find New Life Fighting Coronavirus?The Motley Fool • 10/18/20